Toxicities of novel androgen receptor pathway inhibitor targeted therapies in advanced prostate cancer
As these new treatments are still under development, physicians need to keep up-to-date with potential emerging toxicities and manage acute and long-term toxicities.
Authors
- Diego Teyssonneau (ORCID: https://orcid.org/0000-0002-9687-3759)
- Romain Iaxx
- Guilhem Roubaud
- Virginie Grouthier (ORCID: https://orcid.org/0000-0002-3846-296X)
- Catherine Fallaha
Institutions
- Université de Bordeaux (FR)
- Bordeaux Population Health (FR)
- Institut Bergonié (FR)
- Hôpital du Sacré-Cœur de Montréal (CA)
Publication Details
- Journal
- Current Opinion in Urology
- Published
- 2025-09-18
- DOI
- https://doi.org/10.1097/mou.0000000000001341
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00